Radioembolization for treatment of liver metastases from neuroendocrine tumors: Correlation with imaging and biomarkers

Pancreas

Volumn 42, Issue 2, 2013, Pages 358-360

  Ozao Choy, Junko ^a   Friedman, Marc L ^a   Kim, Amanda S ^a   Wachsman, Ashely ^a   Wolin, Edward M ^a   Yu, Run ^a   Nissen, Nicholas N ^a   Colquhoun, Steven D ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHROMOGRANIN A; PANCREASTATIN; SEROTONIN;

ABDOMINAL PAIN; ADULT; AGED; ARTIFICIAL EMBOLISM; ASCITES; CHOLESTASIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GASTRITIS; HUMAN; LETTER; LIVER METASTASIS; MALE; MEDICAL RECORD REVIEW; NEUROENDOCRINE TUMOR; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; STOMACH ULCER; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INTESTINAL NEOPLASMS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YTTRIUM RADIOISOTOPES;

EID: 84874025562     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31825f4087     Document Type: Letter

References (10)

1. Sutcliffe R, Maguire D, Ramage J, et al. Management of neuroendocrine liver metastases. Am J Surg. 2004;187:39-46.
2. Boudreaux, JP, Putty B, Frey DJ, et al. Surgical treatment of advanced-stage carcinoid tumors: Lessons learned. Ann Surg. 2005;241:839-845.
3. Veenendaal LM, Borel Rinkes IH, Lips CJ, et al. Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy. World J Surg Oncol. 2006;4:35-41.
4. Saxena A, Bester L, Chua TC, et al. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: A preliminary assessment of this novel treatment option. Ann Surg Oncol. 2010;17:484-491.
5. Kalinowski M, Dressler M, Konig A, et al. Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: A prospective single center study. Digestion. 2009;79:137-142.
6. Cao CQ, Yan TD, Bester L, et al. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg. 2010;97:537-543.
7. Rhee TK, Lewandowski RJ, Liu DM, et al. 90Y radioembolization for metastatic neuroendocrine liver tumors: Preliminary results from a multi-institutional experience. Ann Surg. 2008;247:1029-1035.
8. Kennedy AS, Dezarn WA, McNeillie P, et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: Early results in 148 patients. Am J Clin Oncol. 2008;31: 271-279.
9. King J, Quinn R, Glenn DM, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer. 2008;115: 921-929.
10. Jensen EH, Kvols L, McLoughlin JM, et al. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors. Ann Surg Oncol. 2007;14:780-785.